Archive - February 2020
EMA, FDA both accept filing of Novartis’ ofatumumab
Moderna and GSK advance coronavirus vaccine candidates
‘Smart watches’ for Alzheimer’s discussed as numbers set to double by 2050
GSK recruits Clover Biopharmaceuticals in latest coronavirus effort
FDA accepts review to broaden GSK’s Zejula label
Sanofi says it will spin out active ingredient business by 2022
Coronavirus outbreak escalation could impact drug supply chain
Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
